Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity
BACKGROUNDThe role of antibodies in coronavirus disease 2019 (COVID-19) in patients with X-linked agammaglobulinaemia (XLA) has yet to be characterised and clinical courses observed in this cohort of patients have been heterogeneous. Whilst some exhibit spontaneous recovery, others have experienced...
Gespeichert in:
Veröffentlicht in: | Clinical infection in practice 2021, Vol.12, p.100089-100089 |
---|---|
Hauptverfasser: | , , , |
Format: | Report |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!